|
Market Closed -
Japan Exchange
10:30:00 31/08/2026 +04
|
5-day change | 1st Jan Change | ||
| 2,450.50 JPY | -0.26% |
|
+0.10% | +12.80% |
| 07-31 | Ono Pharmaceutical's Profit Rises 37% in Fiscal Q1 | MT |
| 07-31 | Ono Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended June 30, 2026 | CI |
| Market Cap | 1,152B 7.21B 6.21B 5.83B 5.32B 9.99B 686B 10.06B 69.05B 26.87B 348B 27.06B 26.48B | P/E 2027 * |
15.8x | P/E 2028 * | 18.2x |
|---|---|---|---|---|---|
| Enterprise Value | 950B 5.95B 5.12B 4.81B 4.39B 8.25B 566B 8.31B 56.99B 22.17B 287B 22.34B 21.85B | EV / Sales 2027 * |
2.07x | EV / Sales 2028 * | 2.01x |
| Free-Float |
81.92% | Yield 2027 * |
3.19% | Yield 2028 * | 3.15% |
Last Transcript : Ono Pharmaceutical Co., Ltd.
| 1 day | -0.26% | ||
| 1 week | +0.10% | ||
| Current month | +2.79% | ||
| 1 month | -0.28% | ||
| 3 months | +2.42% | ||
| 6 months | -3.66% | ||
| Current year | +12.80% |
| 1 week | 2,420 |  | 2,517.5 |
| 1 month | 2,264.5 | | 2,517.5 |
| Current year | 2,114.5 | | 2,674.5 |
| 1 year | 1,670.5 | | 2,674.5 |
| 3 years | 1,474 | | 2,966.5 |
| 5 years | 1,474 | | 3,990 |
| 10 years | 1,474 | | 3,990 |
| Manager | Title | Age | Since |
|---|---|---|---|
Gyo Sagara
CEO | Chief Executive Officer | 67 | 01/04/2024 |
Masaki Ito
DFI | Director of Finance/CFO | - | 01/04/2026 |
Toichi Takino
PSD | President | 57 | 01/04/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Gyo Sagara
CHM | Chairman | 67 | 01/04/2024 |
Toichi Takino
BRD | Director/Board Member | 57 | 01/06/2020 |
Masao Nomura
BRD | Director/Board Member | 77 | 26/06/2018 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.26% | +0.10% | +47.89% | -11.58% | 7.22B | |
| +3.38% | +4.33% | +24.48% | +78.02% | 48.2B | |
| +0.66% | +0.45% | +57.74% | +122.48% | 39.97B | |
| -2.49% | +3.69% | +18.37% | +84.89% | 12.43B | |
| -1.00% | -1.61% | -11.34% | +14.00% | 12.03B | |
| +0.19% | 0.00% | +29.35% | +150.00% | 9.35B | |
| -1.80% | -1.50% | +25.41% | +48.78% | 7.75B | |
| -1.39% | +6.99% | +28.90% | +228.32% | 7.43B | |
| -0.84% | -2.36% | -36.62% | +16.04% | 5.3B | |
| +1.26% | -1.04% | +45.38% | +108.44% | 4.65B | |
| Average | -0.23% | +1.68% | +22.96% | +83.94% | 15.43B | |
| Weighted average by Cap. | +0.80% | +1.25% | +29.99% | +89.82% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 458B 2.87B 2.47B 2.32B 2.12B 3.98B 273B 4.01B 27.49B 10.7B 138B 10.78B 10.54B | 448B 2.81B 2.42B 2.27B 2.07B 3.89B 267B 3.92B 26.89B 10.46B 135B 10.54B 10.31B |
| Net income | 72.89B 456M 393M 369M 337M 633M 43.41B 637M 4.37B 1.7B 22.01B 1.71B 1.68B | 63.15B 395M 340M 320M 292M 548M 37.61B 552M 3.79B 1.47B 19.07B 1.48B 1.45B |
| Net Debt | -201B -1.26B -1.08B -1.02B -929M -1.75B -120B -1.76B -12.06B -4.69B -60.73B -4.73B -4.62B | -250B -1.56B -1.35B -1.26B -1.15B -2.17B -149B -2.18B -14.97B -5.83B -75.41B -5.87B -5.74B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 31/08/26 | ¥2,450.50 | -0.26% | 1,569,500 |
| 28/08/26 | ¥2,457.00 | +0.04% | 1,269,300 |
| 27/08/26 | ¥2,456.00 | -1.41% | 1,045,700 |
| 26/08/26 | ¥2,491.00 | +1.30% | 1,811,900 |
| 25/08/26 | ¥2,459.00 | +0.61% | 1,772,500 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 4528 Stock
Select your edition
All financial news and data tailored to specific country editions
